Approval · Notice of Compliance 11993 · 2011
NAPROSYN SR: Notice of Compliance 11993
Issued January 6, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11993
- Date
- January 6, 2011
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in wet granulation equipment for drug product manufacturing and concomitant minor changes to the manufacturing process parameters
- Therapeutic class
- Non-steroidal anti-inflammatory drug (NSAID)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROSYN SR | Not yet assigned | — |
Medicinal ingredients
- NAPROXEN 750 MG per TAB